Table 2 Follow-up outcomes of the two patient groups*
| Â | Cemented (n = 28) | Cementless modular (n = 23) | P-value** |
|---|---|---|---|
Preoperative HSS | 79.2 (32–100) | 83.9 (61–100) | 0.195 |
Preoperative VAPS | 0.7 (0–4) | 0.5 (0–3) | 0.499 |
Thigh pain, n (%) | 1 (4%) | 2(9%) | 0.583 |
Femoral bone stock, n (%) | Â | Â | 0.228 |
Bone restoration | 7 (25%) | 11 (48%) | Â |
Constant defects | 15 (54%) | 8 (35%) | Â |
Increasing defects | 6 (21%) | 4 (17%) | Â |
Stem subsidence (mm) | 2.0 (0–8.2) | 1.4 (0–9.3) | 0.304 |
Stem subsidence > 5 mm, n (%) | 1 (4%) | 2 (9%) | 0.583 |
LLD (mm) | 2.4 (0–14) | 2.8 (0–13) | 0.707 |
LLD > 5 mm, n (%) | 5 (18%) | 5 (22%) | 0.739 |
Notable radiolucencies | 4 (14%) | 2 (9%) | 0.678 |
Complications, n (%) | 4 | 7 | 0.190 |
Intraoperative femoral fracture | 0 | 3 (13%) | 0.05 |
Dislocation | 0 | 1 (4%) | 0.451 |
Cortical perforation | 2 (7%) | 3 (13%) | 0.647 |
Nerve injury | 1 (4%) | 0 | 1.000 |
Deep vein thrombosis | 1 (4%) | 0 | 1.000 |
Femoral re-revisions | 1 (4%) | 0 | 1.000 |
Other reoperations | 2 (7%) | 2 (9%) | 0.588 |
